A Study of Aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms in Participants With Major Depressive Disorder Who Experience a Loss of Interest and Pleasure

Clinical trial NCT06635135 · TERMINATED

Trial details

NCT number: NCT06635135
Sponsor: Janssen Research & Development, LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major Anhedonia

Start date: 2024-09-19
Primary completion: 2025-04-09
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.